BNY
Bank Of New York Mellon CorpEvidence as of 2026-10-01The desk's Snapshot
3 of 15 open to everyone · members see allRead the full desk report on BNY
Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.
Free plan, no credit card required. Silver opens the full report, $19.99 a month. AI-written · every claim cites a source · Insight, not advice.
No company profile on file for BNY yet.
Moneyta sentiment
Where the published evidence leans after the desk debated it, not a rating or a recommendation.
+0.4 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled. The rest of the page is the evidence behind it.
Reported quarterly net income rose from $1,220,000,000 in the fiscal quarter ended 2025-03-31 (Q1 2025) to $1,761,000,000 in the fiscal quarter ended 2026-06-30 (Q2 2026), while diluted EPS increased from $1.58 to $2.45 over the same pair of periods. Common shares outstanding (point‑in‑time) fell from 715,434,285 as of 2025-03-31 to 678,504,142 as of 2026-06-30, and cash paid for repurchases increased from $746,000,000 in Q1 2025 to $983,000,000 in the quarter ended 2026-03-31 (Q1 2026).
Market signals are mixed but constructive: the momentum_12_1 measure is +54.7% (87th percentile), six‑month momentum is +22.9% (77th percentile), and the technical state shows a golden cross with price +6.5% above the 200‑day SMA but -8.5% below the 50‑day SMA as of 2026-09-30. Institutional 13F holdings total $83.33B as of 2026-06-30, the share price was 144.63 on 2026-09-30 with market cap $ 98,132,054,057, trailing EPS (TTM) 8.5 giving a P/E (TTM) of 17.02, and trailing twelve‑month free cash flow is negative $ 4,986,000,000.
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else (no outside knowledge, no browsing), so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC (revenue, margins, income, debt and share count, quarter by quarter) and reports which way the trend is running.
Reported quarterly net income increased from $1,220,000,000 in the quarter ended 31 March 2025 to $1,761,000,000 in the quarter ended 30 June 2026.
XBRL companyfacts · 0001390777-25-000084Diluted earnings per share rose from $1.58 in the quarter ended 31 March 2025 to $2.45 in the quarter ended 30 June 2026.
XBRL companyfacts · 0001390777-26-000086Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Which filings the desk reads
The desk reads the annual 10-K in full: its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet; its risk analysis fills in once that lands.
On August 20, 2026, the company filed an 8-K announcing it will redeem 10,000 shares of its Series F Noncumulative Perpetual Preferred Stock and the corresponding depositary shares on September 20, 2026.
8-K filed 2026-08-20A Form 4 filing dated August 31, 2026 is present in the evidence set (the 4 filed 31 August 2026).
4 filed 2026-08-31Reads the signal panel above (momentum, volatility, drawdown, relative strength and beta) and ranks each against the whole research universe rather than judging it in isolation.
Momentum measured as 'momentum_12_1' is +54.7%, which ranks in the 87th percentile of the 567-stock research universe as of 2026-09-30.
Moneyta signal set · 2026-09-30weakened in debateSix‑month momentum is +22.9% and ranks in the 77th percentile of the 567-stock research universe as of 2026-09-30.
Moneyta signal set · 2026-09-30weakened in debateReads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
Institutional 13F-reported holdings total $83.33B as of 2026-06-30, with 1,886 holders and a holder_count_delta_qoq of 367; the reported 13F value_qoq_pct is 65.0.
13F holdings · 1886 filers · as of 2026-06-30BlackRock, Inc. is the largest 13F-reported holder at $8.32B, followed by VANGUARD CAPITAL MANAGEMENT LLC at $6.48B, STATE STREET CORP at $4.60B, FMR LLC at $3.75B, and First Eagle Investment Management, LLC at $2.68B (as reported in the 13F for the period ended 2026-06-30).
13F holdings · 1886 filers · as of 2026-06-30Reads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
A benzinga.com headline on 30 September 2026 frames coverage around a 15-year retrospective of returns by stating how much $1,000 invested in Bank Of New York Mellon would be worth today.
News · benzinga.com · 2026-09-30A kalkinemedia.com headline on 30 September 2026 reports that BNY Senior Executive VP Jose Minaya sold 3,520 shares under a 10b5-1 plan in late September.
News · kalkinemedia.com · 2026-09-30Reads parsed Forms 3/4/5: who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
On 27 August 2026, Minaya Jose (Senior Executive VP) sold 2,590 shares for a total reported value of "$421k", implying an average price of about $162.55 per share; the Form 4 lists these sales as executed under a 10b5-1 plan (stated on the filing).
Form 4 · Minaya Jose (Senior Executive VP) · $421k sold · 2026-08-27On 27 August 2026, Minaya Jose (Senior Executive VP) sold 930 shares for a total reported value of "$152k", implying an average price of about $163.44 per share; the Form 4 lists these sales as executed under a 10b5-1 plan (stated on the filing).
Form 4 · Minaya Jose (Senior Executive VP) · $421k sold · 2026-08-27Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
The share price was 144.63 on 2026-09-30 and the market capitalization was 98,132,054,057.
Valuation inputs · SEC XBRL + stored EOD closeTrailing twelve‑month earnings per share (EPS TTM) are 8.5, implying a reported P/E (TTM) of 17.02.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score. The argument is shown, not hidden, so you can judge the reasoning yourself.
Multiple SEC-filed fundamentals claims together form a coherent favorable signal: rising net income and diluted EPS (fundamentals-0, fundamentals-1) alongside a declining share count and increased repurchases (fundamentals-2, fundamentals-3) indicate improving per‑share profitability metrics that are directly supported by company filings. Market momentum and technical signals (market-0, market-1, market-2) corroborate investor interest and place the stock in the upper percentiles of the covered universe, while institutional ownership data (ownership-0, ownership-1) shows sizable, diversified 13F holdings from major managers, which strengthens the interpretation that the move is supported by large investors. Valuation evidence that P/E (TTM) is ~17.0 (valuation-1) provides a conventional earnings-based frame that is consistent with the reported EPS strength, though free cash flow metrics are flagged separately. The strongest bear points (negative FCF and elevated short‑term volatility) are documented (valuation-2, market-4) and legitimate; however, they are contestable in context because reported net income/EPS improvements and active buybacks are well-sourced in recent 10-Q/10-K filings, and momentum signals rank highly in the research universe, lending moderate-to-strong evidentiary support to a favorable read when weighing earnings and ownership dynamics against cash‑flow and volatility caveats.
Chair's verdict, claim by claim
Fragility · computed, not argued
balanced0.30
33 surviving claims rest on 17 distinct sources; the heaviest analyst carries 18% of them, and 97% of what the desk raised survived the debate.
The evidence set rests on a moderate breadth of sources but a relatively small number of analysts account for a meaningful share of the claims; the largest analyst influence is non‑dominant but not trivial. A very high survival rate from the internal debate means most claims passed scrutiny — that supports usability but also raises the possibility that contested angles were under‑challenged, so treat the read as informative yet somewhat brittle on analyst‑driven assertions.
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment. When the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here (no outside knowledge, no browsing), and each card shows who read it and what it contributed to the score.
14 filings· 2 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data, not retyped or estimated.
Read by Mercer+0.8 to the score
7 documents· 3 cited
SEC filing documents
The filings themselves, including the year-over-year comparison of Item 1A risk factors.
Read by Oakes+0.0 to the score
1 signal set
Moneyta signal set
Computed from our own end-of-day price history and ranked against the whole research universe. No AI involved.
Read by Nash+0.7 to the score
3 holdings records· 1 cited
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+0.5 to the score
2 headlines
News coverage
Recent headlines about this company, rating chatter excluded and nothing published after the report date.
Read by Yatesnothing survived
1 filing
Insider filings
Parsed Forms 3/4/5 from EDGAR: named insiders, share counts, prices, and 10b5-1 plan state, with stated and inferred flags kept apart.
Read by Talbot+0.0 to the score
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
1 record· 0 cited
Analyst consensus
Third-party consensus, shown for context only; it never enters Moneyta sentiment.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal; the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
The full terminal on BNY Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Get this for the names you actually hold
Every name in your portfolio, researched the same way, plus the one thing no sample can show: how each one sits inside what you already own.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.